Treatment with trabectedin: Should be indicated to all soft tissue sarcoma histotypes?

Journal of B.U.ON.

Volumn 15, Issue 4, 2010, Pages 791-793

  Grivas, A ^a   Trafalis, Dimitrios T ^a,b   Thanopoulou, E ^a   Ziras, N G ^a   Athanasiou, A E ^a  

^a METAXA CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Epithelioid sarcoma; ET 743; Fibrosarcoma; Histotype; Soft tissue sarcomas; Trabectedin; Yondelis

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; TRABECTEDIN; VINCRISTINE;

ADULT; ARTICLE; CANCER RELAPSE; CANCER STAGING; CASE REPORT; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; EPITHELIOID SARCOMA; FEMALE; FIBROSARCOMA; HEMOPTYSIS; HUMAN; INDIVIDUALIZATION; LIVER FUNCTION; LIVER TOXICITY; LUNG METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; RADIATION DOSE; SALVAGE THERAPY; SOFT TISSUE SARCOMA; STOMATITIS; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIOXOLES; FEMALE; FIBROSARCOMA; HUMANS; LUNG NEOPLASMS; MALE; PROGNOSIS; SARCOMA; TETRAHYDROISOQUINOLINES;

EID: 78651397155     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Carter NJ, Keam SJ. Trabectedin: A review of its use in the management of soft tissue sarcoma and ovarian cancer. Drugs 2007; 67: 2257-2276.
2. Yovine A, Riofrio M, Blay JY et al. Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients. J Clin Oncol 2004; 22: 890-899.
3. Huygh G, Clement PM, Dumez H et al. Ecteinascidin-743: evidence of activity in advanced, pretreated soft tissue and bone sarcoma patients. Sarcoma 2006; 2006: 1-11.
4. Schöffski P, Wolter P, Clement P et al. Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma. Future Oncol 2007; 3: 381-392.
5. Schöffski P, Dumez H, Wolter P et al. Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma. Expert Opin Pharmacother 2008; 9: 1609-1618.
6. Potamianou A, Ziras N, Bountouroglou N et al. Methotrexate, etoposide, ifosfamide and cisplatin (MVIP): An effective salvage therapy for patients with refractory or relapsed germ-cell tumors. J BUON 2002; 7: 337-345.
7. Grosso F, Jones RL, Demetri GD et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol 2007; 8: 595-602.
8. Verweij J. Ecteinascidin-743 (ET-743) early test or effective treatment in soft tissue sarcomas? J Clin Oncol 2005; 23: 5420-5423.